Working Group Molecular EXposomics

Welcome!

Molecular EXposomics

Molecular EXposomics

Molecular EXposomics

Working Group Molecular EXposomics

MEX is CDC-like laboratory for ultra-trace analysis of organic compounds. It invests into the targeted determination of trace-level biomarkers (eg. neurotransmitters such as thyroid hormones t4-t0, catecholamines etc.) which are key factors in the signaling and the onset of obesity and diabetes as well as neurodegeneration. MEX is proactive in bridging environmental, human, and virtual biomonitoring as well as drug discovery by complementing hyphenated chemical and bioassay based investigations of complex matrices. It enables novel mechanistic studies supportive to actual and coming health strategies and is located in prevention and risk research as well as in enrolling mechanisms of highly potential agents.

More Information: Centers for Disease Control and Prevention

The Exposome

Exposomics is the measurement of all exposures of an individual in a lifetime and how exposures relate to disease (CDC 2010).

Exposomics is the study of the exposome and is related to genomics, metabonomics, lipidomics, transcriptomics, proteomics.

Exposomics includes the study of exposures in the environment.

Biomarkers are targeted to determine exposure and effect.

http://www.cdc.gov/niosh/topics/exposome/

MEX is focusing to target small organic molecules at ultra-trace levels which are involved in the regulation and etiology of diseases.

read more